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normal and diabetic rats. The deficient diet caused a decreaseSelenium-deficient diet induces renal oxidative stress and in-
in the lumen size of the interlobular artery. Se supplementationjury via TGF-b1 in normal and diabetic rats.
to diabetic rats up-regulated mRNA expression for antioxidantBackground. Oxidative stress has been implicated in the
enzymes, and significantly reduced but did not normalize thatpathogenesis of diabetic nephropathy. Although glucose itself
of TGF-b1. Glomerular sclerosis was normalized and the inter-can initiate oxidative stress, deficiency of essential trace ele-
lobular artery lumen size was greatly enlarged in diabetic ratsments such as selenium (Se) may exacerbate this oxidative
by Se supplementation. Also, the tubulointerstitium was pre-stress in diabetic rats. The mechanism by which Se deficiency
served by Se supplementation in diabetic rats.causes oxidative stress and renal injury is not completely under-
Conclusions. The data show that TGF-b1 is a pro-oxidantstood. This study tested the hypothesis that Se deficiency in-
and Se deficiency increases oxidative stress via this growthduces renal oxidative stress and renal injury via transforming
factor. In addition, Se deficiency may simulate hyperglycemicgrowth factor-b1 (TGF-b1).
conditions. Se supplementation to diabetic rats prevents notMethods. Fifty-four male Wistar rats were used. Diabetes was
only oxidative stress but renal structural injury, as well.induced in 27 rats by streptozotocin, and the other 27 rats re-
ceived buffer only. Ten weeks after induction of diabetes, both
normal and diabetic rats were killed, their kidneys removed,
and glomeruli were isolated. Glomeruli from normal and dia-
The pathology of the kidney in diabetes mellitus isbetic rats were incubated in the presence of TGF-b1 alone or
characterized by thickening of the glomerular and tubu-its neutralizing antibody. Antioxidant enzyme (Cu-Zn) super-
oxide dismutase (Cu-Zn SOD), catalase, and glutathione per- lar basement membranes and accumulation of basement
oxidase (GSH-Px) activities; total glutathione; and lipid per- membrane-like material in the mesangium [1]. The mes-
oxidation were determined. For Se studies, 15 normal and 15 angium expands gradually with duration of diabetes anddiabetic rats were divided into groups of five each and fed
becomes the dominant pathologic process causing occlu-either a regular, Se-deficient, or Se-supplemented diet one
sion of the glomerular capillary lumen. Patients withweek after induction of diabetes. Ten weeks after feeding these
diets, rats were killed and glomeruli were isolated. Oxidative marked mesangial expansion demonstrate albuminuria
stress was examined by determining the mRNA expressions and glomerular hypertension. Studies have shown that the
for antioxidant enzymes and also for TGF-b1. Plasma glucose albumin excretion rate of between 20 mg and 300 mg/day,and albuminuria were determined. Histology of the kidney and
called microalbuminuria, is a predictor of glomerular dis-interlobular artery was evaluated by light microscopy.
ease in diabetic patients, and its prevention prolongs theResults. In vitro studies showed that TGF-b1 significantly
reduced glomerular catalase and GSH-Px activities as well as onset of renal failure [2, 3]. Several studies have impli-
total glutathione levels with an increase in lipid peroxidation cated reactive oxygen species (ROS) or oxidative stress
in both normal and diabetic rats. Antibody to TGF-b abrogated as one of the important causes of proteinuria [4–7]. Hy-these changes. There was no effect of TGF-b1 on Cu-Zn SOD.
perglycemia is probably the single most important causeLike TGF-b1, a Se-deficient diet caused a significant decrease
of increased oxidative stress in diabetic animals and hu-in glomerular mRNA expression for Cu-Zn SOD, catalase,
and GSH-Px, but a significant increase in TGF-b1 mRNA mans, because glucose itself can initiate ROS production
expression. Also, a Se-deficient diet caused an increase in albu- [8, 9]. In its enediol form, glucose is prone to transition
minuria, glomerular sclerosis, and plasma glucose levels in both metal-catalyzed autoxidation, yielding hydrogen perox-
ide, hydroxyl radical, and ketoaldehyde. Oxidative stress
implies an overloading of “oxidants” or ROS that dam-Key words: kidney injury, diabetic nephropathy, trace element, albu-
minuria, glomerulosclerosis, antioxidant, hyperglycemia. age a cell. In diabetes, oxidative stress seems mainly due
to both an increased production of plasma or tissue ROSReceived for publication January 26, 2000
concentrations [10–16]. Three primary antioxidant en-and in revised form October 18, 2000
Accepted for publication October 23, 2000 zymes have been demonstrated in mammalian systems
[4, 14]: superoxide dismutase (SOD), catalase, and gluta-Ó 2001 by the International Society of Nephrology
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thione peroxidase (GSH-Px). SOD exists as Cu-Zn SOD Transforming growth factor-b1 is the prototype of a
polypeptide regulatory factor [46–53]. TGF-b1 is multi-and Mn SOD. Cu-Zn SOD, which occurs predominantly in
the cytosol and nucleus, converts superoxide radical into functional, and depending on the metabolic status of the
cell, it can either stimulate or inhibit the same process.hydrogen peroxide, which is then converted to water by
both catalase and GSH-Px. Thus, the three enzymes pre- One of the important functions of TGF-b1 is its effect
on the extracellular matrix proteins such as collagen,vent tissue damage by detoxifying ROS. Besides these
three scavenger enzymes, several endogenous and exog- proteoglycans, fibronectin, and laminin [46–53]. TGF-b1
has the following effects on the extracellular matrix pro-enous antioxidants, such as glutathione, vitamins E, and C,
reduce oxidative burden and maintain normal equilib- teins. (1) It stimulates the synthesis more than the degra-
dation of extracellular matrix proteins, particularly colla-rium. The available evidence indicates a decrease in tissue
and circulating levels of these antioxidant enzymes and gen, by mesangial cells [54]. (2) It regulates enzymes
that degrade extracellular matrix proteins [55, 56]. (3)glutathione in diabetic animals and human subjects [10,
14, 15], and thus increased oxidative stress in diabetes. It increases the expression of cell adhesion molecules
(integrins) of matrix proteins [57]. Collectively, theseSelenium (Se) is an essential trace element, and its
clinical importance in various pathophysiologic condi- processes result in enhanced accumulation of extracellu-
lar matrix components, which is beneficial for woundtions has been increasingly recognized [17–20]. Se is an
integral component at the catalytic sites of the enzyme healing but deleterious to the glomerulus. The latter
becomes sclerosed as in diabetes or other glomerularGSH-Px. Deficiency of Se causes a profound reduction
in the activity of GSH-Px in several tissues, particularly diseases in response to TGF-b1. Because of this function,
TGF-b1 is considered a profibrotic cytokine.in the liver [21–23], resulting in increased oxidative stress.
Se has insulin-like effects because Se supplementation How Se deficiency causes proteinuria and glomerular
sclerosis is not completely understood. In this study, wehas been shown to reduce hyperglycemia and improve
glucose tolerance in diabetic rats without any effect on examined the possibility that Se deficiency causes in-
creased oxidative stress via TGF-b1 in normal and strep-endogenous insulin levels [24–28]. Also, the addition of
sodium selenate to rat adipocytes stimulated glucose tozotocin (STZ) diabetic rats. Although Se deficiency
causes tubulointerstitial disease and glomerular sclerosis,transport [29]. These in vitro insulin-like effects are in
agreement with the observation that insulin-stimulated it is not known whether this dietary deficiency also in-
duces changes in the structure of the renal arteries. Theglucose oxidation was decreased in adipocytes from Se-
deficient rats [30]. Taken together, all of these studies objectives of this study were therefore several-fold: (1)
to examine whether TGF-b1 induces oxidative stress insuggest that Se improves glucose metabolism, and Se
deficiency causes a physiologic condition similar to hy- normal and diabetic glomeruli; (2) to investigate whether
Se deficiency increases glomerular oxidative stress andperglycemia.
Selenium deficiency may simulate hyperglycemic con- TGF-b1 mRNA expression as well as proteinuria in nor-
mal and diabetic rats; (3) to determine whether Se defi-ditions in other aspects as well. For example, Se defi-
ciency has been shown to cause proteinuria in normal ciency causes any structural changes in the tubulointers-
titium and renal arteries; and (4) to test whether Serats [31–33]. This was substantiated by another study in
which proteinuria induced in rats by aminonucleoside of supplementation improves oxidative stress and renal in-
jury in diabetic rats. To our knowledge, studies involvingpuromycin was prevented by Se and vitamin E supple-
mentation [34]. Rats fed a diet deficient in both Se and tubulointerstitium and renal arteries in rats fed either a
Se-deficient or supplemented diet in diabetic rats havevitamin E for 16 weeks demonstrated severe interstitial
disease with an increase in collagen deposition [31]. In not been reported.
diabetic rats, Se supplementation reduced not only pro-
teinuria [27, 35] but glomerular sclerosis as well [35].
METHODS
This is consistent with a human study in which Se supple-
Reagentsmentation reduced albuminuria in patients with diabetic
microvascular complications [36]. Another similarity be- All reagents were purchased either from Sigma Chem-
ical Co. (St. Louis, MO, USA), Ambion, Inc. (Austin,tween Se deficiency and hyperglycemia is that both con-
ditions are associated with up-regulation of renal trans- TX, USA), or R&D Systems (Minneapolis, MN, USA).
forming growth factor-b1 (TGF-b1) mRNA expression
Animals[37, 38]. Lipid peroxidation, which is another mechanism
for oxidative cell damage, is also increased in both condi- A total of 54 male Wistar rats weighing 80 to 100 g
was used. Diabetes was induced in 27 animals by a singletions [38–45]. Thus, there is compelling evidence to im-
plicate Se deficiency or its supplementation in the patho- intraperitoneal injection of STZ (65 mg/kg) in 0.1 mol/L
citrate buffer, pH 4.5. An equal number of control ratsphysiology of renal complications in both diabetic and
nondiabetic conditions. received injections of buffer only. Diabetes was con-
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Table 1. Composition of selenium-deficient diet Preparation of tissue extracts for enzyme assays
Ingredients g/kg % Glomeruli were homogenized in 10 volumes of cold
Torula yeast 300 30 Triton 3 100 (0.2%, vol/vol) for SOD and GSH-Px activ-
Sucrose 590 59 ities, and a 20% glomerular homogenate was prepared
Corn oil 50 5
in 25 mmol/L KH2PO4-NaOH buffer, pH 7.0, for catalaseDL-methionine 3 0.3
Calcium carbonate 12 1.2 activity. The homogenates were centrifuged at 12,000 3 g
Vitamin mixture (Teklad 40060) 10 1.0 for 10 minutes, and the supernatants were used for en-
Mineral mixture (Teklad 80313 with Se omitted) 35 3.5
zyme assays, as described previously [59]. Protein con-
centration was determined in these supernatants by the
method of Lowry et al [60].
firmed (blood glucose .200 mg/dL) in whole blood ob- Enzyme assays
tained from the tail vein, using the glucose reagent strips Superoxide dismutase activity was measured by the
supplied by Sigma Chemical Co. To accomplish the first xanthine-xanthine oxidase cytochrome C method, as de-
objective, 12 normal and 12 diabetic rats were used. scribed previously [59]. The standard assay mixture
Ten weeks after induction of diabetes, both normal and (250 mL) contained 20 mmol/L potassium phosphate
diabetic rats were sacrificed under pentobarbital anes- buffer, pH 7.8, 0.1 mmol/L ethylenediaminetetraacetic
thesia (5 mg/100 g). Kidneys were excised and glomeruli acid (EDTA), 0.2 mmol/L ferricytochrome C, 50 mmol/L
were isolated, as described by a previous method [58]. xanthine, and 10 mmol/L fresh potassium cyanide. The
To accomplish the other objectives, 15 normal and 15 reaction was initiated with sufficient xanthine oxidase to
diabetic rats were divided into groups of 5 rats each and cause an increase in absorbance of 0.025 per minute at
fed a basal (regular) diet containing 0.27 mg/kg Se, Se- 550 nm. Total SOD was determined in 0.2% Triton 3
deficient diet (,0.025 mg/kg), or Se-supplemented diet 100 glomerular supernatant (20 mL) and Cu-Zn SOD in
(0.78 mg/kg) for 10 weeks. These diets were started one CHCl3/methanol extract. CU-Zn SOD was calculated as
week after establishment of diabetes. Both Se-deficient the difference between total SOD and Mn-SOD. One
and regular diets were supplied by Bio-Serv (French- unit of SOD activity was defined as the amount of en-
zyme that causes a 50% inhibition of the reaction undertown, NJ, USA). The composition of the Se-deficient
standard conditions. The enzyme activity was expresseddiet is shown in Table 1. Se is added as sodium selenite.
as units per milligram of protein.This synthetic diet provided the following percentages:
Catalase activity was assayed by the method of Johans-15.05% protein, 6.45% fat, 2.89% fiber, 1.03% moisture,
son and Ha˚kan Borg [61]. The method is based on theand 69.20% carbohydrate. All diets were isocaloric and
reaction of catalase from tissue sample with methanolprovided 3.958 kcal/g. All rats were allowed to eat and
in the presence of hydrogen peroxide. The formalde-drink tap water ad libitum. At the end of the study,
hyde produced was measured with Purpald (4-amino-each rat was placed in a metabolic cage, and a 24-hour
3-hydrazino-5-mercapto-1,2,4-triazole) as a chromogen.consumption of food and water as well as urine volume
The reaction mixture contained in a total volume ofwas collected.
210 mL: 50 mL 250 mmol/L buffer, 50 mL 100% methanol
(wt/vol), 10 mL 27% hydrogen peroxide (wt/vol), andEffect of TGF-b1 on glomerular antioxidant enzymes,
100 mL glomerular supernatant and incubated with con-glutathione, and lipid peroxidation
tinuous shaking for 20 minutes at room temperature. The
Glomeruli from two to three rats were pooled and reaction was terminated by addition of 50 mL 7.8 mol/L
incubated for six hours in the presence of TGF-b1 (5 KOH followed by addition of 100 mL 34.2 mmol/L pur-
and 10 ng/mL) or TGF-b1 plus antibody to TGF-b (5 pald and continuous shaking for 10 minutes. To obtain
and 10 ng/mL) or antibody alone (5 ng/mL) for determi- a colored compound, 50 mL 65.2 mmol/L potassium peri-
nations of antioxidant enzymes, glutathione, and lipid odate were added, and the sample centrifuged to precipi-
peroxidation. The neutralizing antibody was a polyclonal tate any particulate material. The absorbance of the clear
antibody, which is a cocktail of recombinant TGF-b1, supernate was measured at 550 nm in a spectrophotome-
porcine TGF-b1–2, porcine TGF-b2, and rat TGF-b5. ter. Catalase activity was expressed as units/mg protein.
The viability of glomeruli for six hours in the incubation Glutathione peroxidase activity was measured by the
medium was documented by linear increase in one of the procedure of Paglia and Valentine [62] as modified by
antioxidant enzyme (catalase) activities from 2 to 12 hours. L’Abbe and Trick [63], in which the oxidation of GSH
Enzyme activity (U/mg protein) at 2, 4, 6 and 12 hours and NADPH are coupled in the presence of glutathione
was 7.80 6 0.2, 16.92 6 1.14, 44.17 6 2.05, and 74.00 6 reductase. The reaction mixture contained in a total vol-
ume of 250 mL: 150 nmol/L potassium phosphate buffer,2.60 (mean 6 SEM), respectively.
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pH 7.0, 5 mmol/L EDTA, 0.5 mmol/L sodium azide, Inc. The plasmid DNA was linearized with Xbal enzyme,
and suitable RNA polymerase was used to synthesize2 mmol/L GSH, 0.26 mmol/L NADPH, and 1 U/mL gluta-
thione reductase and glomerular supernatant (1.25 mL). antisense b-actin RNA probe.
The reaction was initiated by adding 1.2 mmol/L t-butyl
Urinary albumin and plasma glucosehydroperoxide as substrate. One unit of enzyme activity
was defined as the oxidation of 1.0 mmol of NADPH/ Urinary albumin concentration was determined by the
radioimmunoassay method of Brodows et al [66] andmin in the system described and expressed as mU/mg
protein. plasma glucose by the glucose oxidase method, using the
reagents supplied by Sigma Chemical Co.
Total glutathione and lipid peroxidation
Histology of the kidneyImmediately after isolation of glomeruli, a 5% homog-
enate was made with 5% sulfosalicylic acid and centri- Coronal sections of the kidney (2 mm thick) were
stained with periodic acid-Schiff and examined by lightfuged. Total tissue glutathione was determined by the
DTNB [5-59-dithiobis (2-nitrobenzoic acid)]-glutathione microscopy in a blinded fashion to the animal group.
The following measurements were made.reductase recycling assay as described by Anderson [64].
Total glutathione content was expressed as nmol/mg pro-
Glomerular morphometrytein. Lipid peroxidation was assessed by the production
of malonylaldehyde, using thiobarbituric acid [40], and In each animal, 20 glomeruli were examined for glo-
merular volume and fractional mesangial area by digitalexpressed as nmol of thiobarbituric acid reactive sub-
stances/mg protein. image analysis using the software Image-proPlus (ver-
sion 3.0) system developed by Media Cybernetics (Media
Quantitation of mRNAs for antioxidant enzymes Cybernetics, Silver Spring, MD, USA). Instrumentation
and TGF-b1 consisted of a microscope, a microscope-mounted CCD
camera (768 3 493 resolution), and an IBM computerGlomeruli were lyzed and denatured by 4 mol/L guani-
dinium thiocyanate, 25 mmol/L sodium citrate (pH 7.0), with a color video screen for projecting and manipulating
the images. Images of glomeruli at 3400 magnification0.5% sarcosylm and 0.1 mol/L 2-mercaptoethanol. Total
RNA was extracted by the method of Chomczynski and were digitized, presented in pseudo-color, and saved.
The digitized images were then projected on the com-Sacchi [65]. Twenty micrograms of total RNA were used
for each assay. Rat Cu-Zn SOD (nucleotides 50 to 429), puter screen and analyzed at a resolution of 768 3 493
pixels. The glomerular area or volume, defined as the cross-catalase (nucleotides 588 to 1011), and GSH-Px (nucleo-
tides 29 to 345) cDNAs were kindly provided by Dr. sectional area (CSA) of the renal corpuscle bounded
by the Bowman’s capsule, was determined by manuallyJonathan L. Tilly (Massachusetts General Hospital, Bos-
ton, MA, USA) and rat TGF-b1 (nucleotides 601 to outlining the Bowman’s capsule on the image screen
using the cursor, and the area was automatically calcu-1586) by Dr. Michael B. Sporn (National Institutes of
Health, Bethesda, MD, USA). The plasmid DNAs lated by the computer. The area of the mesangial matrix
was measured by pseudo-color image to aid visualizationcloned in pGEM 4Z vector were linearized with BamHI
enzyme, and antisense RNA probes were generated by of the mesangium. The fractional mesangial area was
expressed as a percentage of the glomerular area.T7 RNA polymerase using a-32P-UTP (800 Ci/mmol).
Full-length transcripts were recovered by running a 5%
Morphometry of interlobular arteryurea acrylamide gel. Electrophoretically eluted tran-
scripts were ethanol precipitated and used for hybridiza- Sections stained with periodic acid-Schiff were exam-
ined for various characteristics of the artery [67]. Mea-tion. Each labeled riboprobe (2 3 1024 to 8 3 1024;
Promega, Madison, WI, USA) was hybridized with total surements of morphometric parameters were performed
by digital image analysis, as described previously in thisRNA overnight at 378C and protein was removed by
using sarcosyl and proteinase K digestion (2 g). The article. The interlobular artery was identified as a single
muscular artery within the inner cortex and at times lyinghybrid RNA was extracted in TE saturated phenol:chlo-
roform and precipitated with absolute alcohol. The pre- close to the glomerulus. Arteries that were not sectioned
transversely (that is, wall thickness was asymmetrical)cipitate was diluted in 10 mL of loading buffer and pre-
heated for three to five minutes at 958C before loading were excluded from the study. Therefore, two to five
arteries from each animal were evaluated. Images of theon to a 5% urea acrylamide gel. The gel was run at 250 V
for one hour and exposed to a Fuji film overnight, and arteries at 3400 magnification were digitized and saved.
The digitized images were then projected on the com-autoradiograms were developed. b-Actin mRNA was
used as an internal control. p-TRI-b-actin plasmid DNA puter screen and analyzed at a resolution of 768 3 493
pixels. The total CSA (CSAtot) of the artery, defined ascontaining 126 bp cDNA fragment of rat b-actin gene
(nucleotides 2682 to 2779) was purchased from Ambion, the CSA of the lumen plus the vessel wall, was deter-
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Table 2. Effect of transforming growth factor-b1 (TGF-b1) on antioxidant enzymes, total glutathione and lipid peroxidation (TBARS) in
glomeruli from normal (N) and diabetic (D) rats
TGF-b1 1 TGF-b antibody
TGF-b1 TGF-b antibody without TGF-b1
Parameter Rats Control 5 ng/mL 10 ng/mL 5 ng/mL 10 ng/mL 5 ng/mL
Cu-Zn SOD N 26.3763.10 (6)a 25.3262.06 (6) 27.6662.41 (6) 27.3962.48 (6) 24.7062.95 (6) 21.1662.16 (4)
U/mg protein D 17.4262.01 (6) 17.9861.55 (6) 17.9961.38 (6) 16.1261.70 (6) 17.7360.80 (6) 16.6561.02 (4)
Catalase N 57.9561.88 (6)a 37.7161.87 (6)b 41.2161.39 (6)b 53.4261.06 (5) 56.0761.57 (5) 59.8061.62 (4)
U/mg protein D 35.3361.14 (6) 24.2661.32 (5)d 25.6360.83 (5)d 33.3860.73 (5) 36.2861.29 (5) 34.4860.57 (5)
Glutathione Px N 231.21611.91 (4)a 171.8367.91 (6)b 187.3066.99 (5)c 207.35615.12 (4) 213.8266.00 (4) 230.56611.30 (4)
mU/mg protein D 128.1764.57 (5) 119.7068.48 (6) 100.9362.11 (4)d 134.4663.60 (4) 125.29610.80 (5) 129.4064.92 (4)
Glutathione N 31.6761.36 (5)a 30.6661.63 (6) 27.2461.04 (4) 29.4061.10 (6) 25.9360.41 (6) 29.0061.09 (4)
nmol/mg protein D 22.6061.16 (6) 22.0061.31 (6) 16.4361.04 (4)e 20.4861.50 (5) 21.5360.79 (5) 21.0060.83 (4)
TBARS N 1.9460.08 (6)a 1.8960.06 (4) 2.4960.12 (6)c 2.1760.09 (4) 2.0760.15 (6) 2.0960.08 (4)
nmol/mg protein D 2.3260.05 (6) 2.3060.09 (6) 2.8260.18 (5)e 2.3860.10 (6) 2.4960.10 (6) 2.4760.14 (4)
Each value represents the mean 6 SEM. Numbers in parentheses represent number of determinations.
Abbreviations are: TBARS, thiobarbituric acid reactive substances; SOD, superoxide dismutase; Px, peroxidase.
a Normal vs. diabetic, P , 0.05–0.005 (comparison includes controls as well as TGF-b1 and its antibody)
b Control vs. TGF-b1 (5 ng/mL), P , 0.001
c Control vs. TGF-b1 (10 ng/mL), P , 0.0.025-0.001
d Control vs. TGF-b1 (5 or 10 ng/mL), P , 0.001
e Control vs. TGF-b1, P , 0.01 (glutathione) or P , 0.02 (TBARS)
mined by manually outlining the external circumference the significance between normal and diabetic rats. Re-
of the vessel on the image screen using the cursor, and sults are expressed as mean 6 SEM; a P value , 0.05
the area was automatically calculated by the computer. was considered significant.
Then, the luminal CSA (CSAlum) was determined by giv-
ing pseudo-color to the lumen image, and the area was
RESULTScalculated by the computer. The short and long internal
The effects of TGF-b1 and neutralizing antibody todiameters of the vessels, defined as the shortest and
TGF-b on antioxidant enzymes, total glutathione, andlongest distances between the two perpendicular lines
thiobarbutiric acid reactive substances (TBARS) in nor-across the vessel from one adluminal side of the internal
mal and diabetic glomeruli are shown in Table 2. Aselastic lamina to the other, were measured.
evident, the enzyme activities of Cu-Zn SOD, catalase,The media CSA of the vessel was calculated as:
and GSH-Px were significantly lower in diabetic than in
CSA 5 (CSAtot 2 CSAlum) 3 (IDshort /IDlong) normal rats. Similarly, the glomerular glutathione con-
centration was significantly lower in diabetic rats. In con-where CSAtot and CSAlum are the total (lumen plus vessel
trast, the lipid peroxidation, as measured by TBARS,wall) and luminal CSAs, respectively, and IDshort and
was significantly higher in diabetic than in normal rats.IDlong are the short and long internal diameters, respec-
TGF-b1 has no effect on Cu-Zn SOD either in normaltively. The external diameter (ED) was determined from:
or diabetic glomeruli. TGF-b1 either at 5 or 10 ng/mL
ED 5 2 3 (CSAtot 3 IDshort /IDlong /p)1/2 significantly lowered catalase and GSH-Px activities as
well as glutathione levels and increased lipid peroxida-Media thickness was determined from (ED 2 IDshort)/2,
tion in both normal and diabetic glomeruli. These changesand the media-lumen ratio from (ED 2 IDshort)/2/IDshort.
induced by TGF-b1 were abrogated by its neutralizing
Tubulointerstitium antibody in either the presence or absence of TGF-b1.
Table 3 shows general information on normal or dia-The pathology of the tubulointerstitium was evaluated
betic rats fed either a regular, Se-deficient, or Se-supple-semiquantitatively for the presence of (1) tubular dila-
mented diets for 10 weeks. As evident, the body weighttion, (2) tubular atrophy and disrupted tubular basement
was significantly lower (P , 0.001) in diabetic comparedmembrane, (3) interstitial fibrosis, and (4) interstitial
with normal rats. In general, the kidney weight, 24-hourinflammatory cell infiltrates [68].
food intake, water intake, urine volume, and albuminuria
Statistical analysis were significantly higher in diabetic than in normal rats.
Plasma glucose levels were also higher in diabetic rats.Multiple-group comparisons were analyzed by one-
No differences were observed in food intake, water in-way analysis of variance. When significant F values were
take, and urine volume among normal or diabetic groups.noted among groups, post hoc analyses were performed
using Tukey’s test. Student t test was used to calculate However, Se deficiency caused a significant increase in
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Table 3. General information on rats fed either a regular, selenium-deficient (Se2) or selenium-supplemented (Se1)
diet at the time of killing
Normal Diabetic Normal Diabetic Normal Diabetic
Parameter Regular Se2 Se1
Body weight g 537622a 364615 510632 397620 496627 387621
Kidney weight g 3.7160.4a 6.1860.37b 3.9560.17 6.0760.35 3.6160.13 5.0760.20
Food intake
g/day 25.2062.08a 49.2063.00 25.0061.26 47.4061.50 21.2060.86 46.4064.40
Water intake
mL/day 47.0063.00a 330.0067.90 44.0064.80 252.0067.10 47.0067.68 334.00640.90
Urine volume
mL/day 26.8063.26a,c 177.2068.90 32.8065.01 168.4065.00 31.8065.78 172.6063.60
Plasma glucose
mg/dL 188610a,c 63067d 246614 771643 18567 638628
Urinary albumin
mg/day 4.2460.31a 18.8260.87d 7.3860.18 33.3061.14 4.5260.30 15.8662.50
Each value represents the mean 6 SEM. N 5 5 rats in each group.
a Normal vs. diabetic (regular diet), P , 0.001
b Diabetic (regular diet) vs. diabetic (Se1 diet), P , 0.05
c Normal (regular diet) vs. normal (Se2 diet), P , 0.05–0.001
d Diabetic (regular diet) vs. diabetic (Se2 diet), P , 0.05–0.001
plasma glucose and urinary albumin levels in both nor- rats fed either regular, Se-deficient, or Se-supplemented
diets. However, the fractional mesangial area was sig-mal and diabetic rats. In diabetic rats, Se supplemen-
tation did not normalize either plasma glucose or albu- nificantly greater in diabetic compared with normal rats.
Se deficiency significantly increased the mesangial areaminuria. However, the kidney weight was significantly
reduced by Se supplementation in diabetic rats. No effect in both normal and diabetic rats. Se supplementation
normalized this mesangial area in diabetic rats.of Se supplementation was observed on any of these
parameters in normal rats. Figure 5 shows representative glomeruli from various
groups of rats. Glomerular sclerosis is more prominent inFigure 1 demonstrates glomerular mRNA levels ex-
pressed as relative density units after normalization with diabetic than in normal rats fed a regular diet. Se defi-
ciency increased sclerosis in both groups of rats. Supple-b-actin for antioxidant enzymes in various groups of rats.
The mRNA expression for Cu-Zn SOD and GSH-Px mentation of Se to diabetic rats reversed glomerular scle-
rosis in diabetic rats, but without any effect in normal rats.were significantly higher and that for catalase signifi-
cantly lower in diabetic compared with normal rats. In Morphometric characteristics of interlobular arteries
are shown in Table 4. As evident, diabetic rats had sig-Se-deficient rats, the mRNA expression for all these
enzymes was significantly lower in both normal and dia- nificantly increased total vessel area and decreased me-
dia:lumen ratio than normal rats. The decreased me-betic rats compared with rats fed a regular diet. Supple-
mentation of Se to diabetic rats significantly increased dia:lumen ratio indicates an increase in lumen size in
diabetic rats (Fig. 6). However, no difference either inmRNA levels for all antioxidant enzymes compared with
rats fed a regular or Se-deficient diets. Figure 2 shows media area, external diameter, or media thickness was
observed between normal and diabetic rats fed a regularrepresentative autoradiograms of mRNAs for antioxi-
dant enzymes in various groups of animals. diet. In normal rats, Se-deficient diet caused a significant
increase in the media:lumen ratio, suggesting a decreaseFigure 3 shows glomerular mRNA levels for TGF-b1.
As evident, glomeruli from diabetic rats expressed more in lumen size. In diabetic rats, Se deficiency significantly
decreased total vessel area, media area, and external diam-message than glomeruli from normal rats. Se deficiency
caused a significant increase in glomerular expression of eter, but increased media:lumen ratio without any effect
on luminal area or media thickness. Although Se supple-mRNA for TGF-b1 in normal rats, and this expression
was even more pronounced in diabetic rats compared mentation did not have any significant effect on the inter-
lobular artery in normal rats, it had a profound beneficialwith rats fed a regular diet. Se supplementation signifi-
cantly improved but did not normalize TGF-b1 expres- effect in diabetic rats (Fig. 6). The total vessel and lumi-
nal areas and external diameter were significantly in-sion in diabetic rats. However, Se supplementation had
no effect in normal rats. creased, whereas the media:lumen ratio was significantly
reduced compared with diabetic rats fed a regular diet.Glomerular volume and fractional mesangial area in
normal and diabetic rats fed different diets are shown However, both media area and thickness were not influ-
enced by Se supplementation in diabetic rats.in Figure 4. As evident, no difference in glomerular vol-
ume was observed between normal and diabetic rats or Histologic examination of the tubulointerstitium showed
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no abnormalities in normal rats fed either a regular, Se-
deficient, or Se-supplemented diets. In contrast, diabetic
rats fed a regular diet showed focal areas of tubular
dilation, atrophy, and interstitial fibrosis (Fig. 7). Also,
occasional rupture of the tubular basement membrane
was observed in these diabetic rats (data not shown).
The Se-deficient diet did not exacerbate any of these
lesions; however, diabetic rats fed a Se-supplemented
diet did not show any of the previously mentioned abnor-
malities in the tubulointerstitium. There were no in-
flammatory cellular infiltrates in any group of rats.
DISCUSSION
This study demonstrates several important observa-
tions. (1) TGF-b1 induces oxidative stress in vitro in
the kidneys of both normal and diabetic rats, and this
oxidative stress is abrogated by the antibody to TGF.
(2) Similar to TGF-b1, Se deficiency induces oxidative
stress in vivo in both normal and diabetic rats by reducing
glomerular expression of mRNAs for antioxidant en-
zymes with an up-regulation of glomerular mRNA ex-
pression for TGF-b1. (3) Se deficiency increases albu-
minuria in both normal and diabetic rats, but renal
growth in the diabetic rat only. (4) Se deficiency increases
glomerular sclerosis and fractional mesangial area in nor-
mal and diabetic rats. (5) Se deficiency increases plasma
glucose concentration in normal rats with further exacer-
bation in diabetic rats. (6) Se deficiency causes decreased
lumen size of the interlobular artery in both normal and
diabetic rats, and (7) Se supplementation to diabetic rats
reduces the kidney weight, up-regulates antioxidant en-
zyme mRNAs, and significantly improves but does not
normalize TGF-b1 mRNA levels. Also, Se supplementa-
tion not only reverses glomerular sclerosis, but also greatly
enlarges the lumen size of the interlobular artery in these
diabetic rats. However, plasma glucose levels and albu-
minuria were not significantly affected by Se supplemen-
tation in diabetic rats. Se supplementation did not have
any effect in normal rats.
The induction of oxidative stress by TGF-b1 was re-
ported in several in vitro studies [69–74]. First, TGF-b1
has been shown to produce an oxidant effect on pulmo-
nary vascular endothelial cells that is capable of causing
injury to the endothelium [69]. Second, TGF-b1 causedFig. 1. RNase protection assays for glomerular mRNAs for Cu-Zn
suppression of mRNA expression for SOD and catalasesuperoxide dismutase (Cu-Zn SOD), catalase, and glutathione peroxi-
dase (GSH-Px) in normal (h) and diabetic (j) rats fed a regular (R) by rat hepatocytes [70] and that of catalase and GSH-Px
diet containing 0.27 mg/kg selenium (Se) or a Se-deficient (Se2) or a by pancreatic b-cells [71]. Third, TGF-b1 has been shownSe-supplemented (Se1; 0.78 mg/kg) diet for 10 weeks. Values were
to decrease catalase and GSH-Px activities in pancreaticnormalized to corresponding b-actin and expressed as relative density
units. *P , 0.001 normal R vs. diabetic R. There were five animals in b-cells [71] and vascular smooth muscle cells [72], and
each group.
finally, TGF-b1 has been shown to induce hydrogen per-
oxide production by human lung fibroblasts [73] and he-
patic stellate cells [74]. However, these studies did not
utilize the neutralizing antibody to TGF-b to document
the specificity of TGF-b1 effect. Our in vitro studies of
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Fig. 2. Representative autoradiograms of
mRNAs for Cu-Zn superoxide dismutase
(SOD), catalase (CAT), and glutathione per-
oxidase (GSH-Px) in normal (N), diabetic
(D), selenium-deficient (Se2), or selenium-
supplemented (Se1) rats.
Fig. 3. RNase protection assay for glomerular mRNA for TGF-b1
expressed as density units (A) and representative autoradiograms (B)
in normal (h; N) and diabetic (j; D) rats fed a diet containing either
a regular (R) amount of selenium (Se) or a Se-deficient (Se2) or a Se-
supplemented (Se1) diet for 10 weeks. Values were normalized to
corresponding b-actin and are expressed as relative density units. *P ,
0.001 normal R vs. diabetic R. There were five animals in each group.
TGF-b1 and its antibody support these earlier studies and
implicate this growth factor in the induction of oxidative
stress.
To our knowledge, the observed increase in lipid per-
oxidation and the decrease in total glutathione content
by TGF-b1 in both normal and diabetic glomeruli have
not been reported previously. This increase in lipid per-
oxidation may be due to a decrease in GSH-Px activity
induced by TGF-b1.
The oxidative stress induced by TGF-b1 has also been
observed in Se-deficient normal and diabetic rats. Al-
though diabetes caused up-regulation of Cu-Zn SOD
and GSH-Px mRNA expression, Se deficiency caused
down-regulation of these messages. These disparate ef-
fects are difficult to explain at this time; however, Se
and hyperglycemia seem to play different roles in the
transcriptional regulation of these enzymes. Thus, it is of Fig. 4. Glomerular morphometry in normal ( ) and diabetic (j)
rats fed a diet containing either a regular (R) amount of selenium (Se)interest to note that Se deficiency down-regulates rather
or a Se-deficient (Se2) or a Se-supplemented (Se1) diet for 10 weeks.than up-regulates the mRNA expression for antioxidant *P , 0.001 normal R vs. diabetic R. There were five animals in
each group.enzymes. Although Se deficiency increases the expres-
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Fig. 5. Photomicrographs of representative
glomeruli from rats fed either a regular, sele-
nium-deficient (Se2), or Se-supplemented
(Se1) diet for 10 weeks. (A) Normal rat fed
a regular diet. (B) Normal rat fed a Se2 diet.
(C ) Normal rat fed a Se1 diet. (D) Diabetic
rat fed a regular diet. (E) Diabetic rat fed a
Se2 diet. (F ) Diabetic rat fed a Se1 diet.
Periodic acid-Schiff 3400.
Table 4. Characteristics of interlobular artery determined by morphometric study in normal and diabetic rats fed either a regular,
selenium-deficient (Se2) or selenium-supplemented (Se1) diet
Normal (5) Diabetic (5) Normal (5) Diabetic (5) Normal (5) Diabetic (5)
Parameter Regular Se2 Se1
Total vessel area lm2 38576293a 46166104e 38006260 29726244 42446545c 69816615f
Luminal area lm 10726103 12806157 9946102 10586259 13016293c 29266323f
Media area lm2 16206243 21416188e 15286249 12146126 17316243c 24366150
External diameter lm 47.5762.02 55.2563.34e 50.3862.37b 44.1361.17 56.2963.46c 72.2962.48f
Media thickness lm 12.5860.84 11.9060.84 13.4261.50 11.4060.81 12.3060.97 12.8060.64
Media:lumen ratio 0.5160.03a,d 0.4060.03e 0.6860.05 0.5660.03 0.4360.04c 0.2860.02f
Values shown are mean 6 SEM. Numbers in parentheses represent number of animals in each group.
a Normal vs. diabetic (regular diet), P , 0.05–0.03
b Normal (regular diet) vs. diabetic (Se2 diet), P , 0.05
c Normal vs. diabetic (Se1 diet), P , 0.05–0.01
d Normal (regular diet) vs. normal (Se2 diet), P , 0.03
e Diabetic (regular diet) vs. diabetic (Se2 diet), P , 0.02–0.001
f Diabetic (regular diet) vs. diabetic (Se1 diet), P , 0.02–0.01
sion of TGF-b1, the possible link between oxidative stress, uria [75, 76]. Although Se supplementation did not nor-
malize TGF-b1 mRNA expression and albuminuria inand the molecular mechanism by which this growth fac-
tor reduces antioxidant gene expression remains to be diabetic rats, glomerular sclerosis was normalized. This
suggests that modest Se intake seems to counteract theelucidated. Our data of Se deficiency-induced up-regula-
tion of TGF-b1 expression and down-regulation of anti- fibrogenic action of TGF-b1, and normalization of this
growth factor may take longer than 10 weeks of Se sup-oxidant enzyme expression are consistent with those of
Nath et al [38], who also demonstrated an increase in plementation. Improvement in proteinuria by Se supple-
mentation has been observed in animals [27, 34, 35] andcortical expression of mRNA for TGF-b1 and a decrease
in gene expression for GSH-Px and catalase in rats fed human subjects [36]. In the present study, the observed
dissociation between albuminuria and glomerular sclero-a diet deficient in Se and vitamin E. Also, decreases in
hepatic and renal mRNA expression for GSH-Px have sis is difficult to explain; however, small number of ani-
mals and variability in albumin levels may be responsiblebeen observed in Se-deficient rats [21–23].
The mechanism by which Se deficiency causes protein- for this discrepancy. Although prevention of glomerular
sclerosis in diabetic rats by Se supplementation has beenuria and glomerular sclerosis is not clearly understood.
The results of the present study implicate TGF-b1 as reported by Douillet et al [35], the present study docu-
ments, to our knowledge for the first time, such a beneficialthe mediator of renal injury, because of the involvement
of this growth factor in fibrogenesis [46–53] and protein- effect by morphometric evaluation. Also, Se supplementa-
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Fig. 6. Photomicrographs of representative
interlobular arteries from rats fed either a reg-
ular, selenium-deficient (Se2), or selenium-
supplemented (Se1) diet for 10 weeks. (A)
Normal rat fed a regular diet. (B) Normal rat
fed a Se2 diet. (C ) Normal rat fed a Se1
diet. (D) Diabetic rat fed a regular diet. (E)
Diabetic rat fed a Se2 diet. (F ) Diabetic rat
fed a Se1 diet. Periodic acid-Schiff 3400.
Although focal areas of tubulointerstitial disease were
observed in diabetic rats, exacerbation of these lesions
was not observed in rats fed a Se-deficient diet. This lack
of effect of Se deficiency may be due to the short duration
of feeding the deficient diet, since Nath et al [38] also
failed to observe severe interstitial disease in rats fed a
diet deficient in Se and vitamin E for 12 weeks. The
observation that diabetic rats given excess Se in diet did
Fig. 7. Photomicrograph of the tubulointerstitium in normal (A) and not demonstrate any tubulointerstitial disease provides
diabetic (B) rats fed a regular diet. Periodic acid-Schiff 3400. an indirect evidence that Se supplementation may be
beneficial in preserving tubulointerstitium.
In summary, our data show that TGF-b1 is a pro-
tion has been found to reduce the kidney weight in diabetic oxidant and that Se deficiency increases oxidative stress
via this growth factor. In addition, Se deficiency mayrats.
simulate hyperglycemic conditions. This conclusion isSelenium deficiency, like insulin deficiency, caused a
based on observations that both conditions increasesignificant increase in plasma glucose levels in normal
TGF-b1 expression, induce oxidative stress, cause albu-rats with exacerbation in diabetic rats. This suggests that
minuria and glomerular sclerosis, and elevate plasmaSe has insulin-like effects, and the observation is similar
glucose levels. Se supplementation to diabetic rats pre-to that of other investigators [24–28]. However, Se sup-
vents not only oxidative stress but renal structural injuryplementation failed to lower plasma glucose levels in
as well. Long-term studies with Se supplementation indiabetic rats. Probably lowering plasma glucose may take
diabetic rats are clearly indicated.a longer duration of Se supplementation.
To our knowledge, this is the first report to evaluate
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